MC38-hFOLR1/hCD47(2)
Strain Information
Validation Data
Fig1. Analysis of hFOLR1 and hCD47 expression in in vitro cultured MC38-hFOLR1/hCD47 cells by FACS.
Fig2. In vivo validation of MC38-hFOLR1/hCD47 in C57BL/6 mice. C57BL/6 mice were inoculated with MC38-hFOLR1/hCD47 subcutaneously at 1×106 cells /mouse inoculum for tumor development.
Fig3. hFOLR1 and hCD47 expression in tumors after in vivo growth of MC38-hFOLR1/hCD47 in wild type C57BL/6 mice. The tumors were collected at day 25 post tumor cell inoculation.
Fig4. hFOLR1 and hCD47 expression in tumors after in vivo growth of MC38-hFOLR1/hCD47 in wild type C57BL/6 mice. The tumors were collected at day 35 post tumor cell inoculation.
Related Strain(s)
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
